UPMC/X
May 9, 2025, 11:53
Robert Ferris Highlights Breakthrough Ewing Sarcoma Drug Discovery from UNC Lineberger
Robert Ferris, Executive Director at UNC Lineberger Comprehensive Cancer Center, shared UNC Lineberger Comprehensive Cancer Center’s post on X, adding:
“Impressive result from a large drug screen driven by deep knowledge and harnessing of tumor biology, working to move therapeutics to the clinic as rapidly as possible!”
Quoting UNC Lineberger Comprehensive Cancer Center’s post:
“Researchers at UNC Lineberger have developed a small molecule that selectively degrades a protein implicated in Ewing sarcoma, a rare and aggressive cancer of the bone and soft tissue that primarily affects children and teenagers.
The preclinical study points to a potential new therapeutic approach for a disease with limited treatment options when standard therapies fail.”
See OncoDaily’s impactful insight about Ewing Sarcoma.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 9, 2025, 11:53
May 9, 2025, 11:38